{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T14:57:13Z","timestamp":1772117833820,"version":"3.50.1"},"publisher-location":"Chichester, UK","reference-count":18,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd009202.pub2","type":"reference-entry","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T11:59:10Z","timestamp":1344427150000},"source":"Crossref","is-referenced-by-count":9,"title":["Propofol versus thiopental sodium for the treatment of refractory status epilepticus"],"prefix":"10.1002","author":[{"given":"Hemanshu","family":"Prabhakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Bindra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyaninder Pal","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mani","family":"Kalaivani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"key":"10.1002\/14651858.CD009202.pub2-BIB1|cit1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12028-010-9445-z","article-title":"A randomized trial for the treatment of refractory status epilepticus","volume":"14","author":"Rossetti","year":"2011","journal-title":"Neurocritical Care"},{"issue":"2","key":"10.1002\/14651858.CD009202.pub2-BIB2|cit2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1046\/j.1528-1157.2002.28501.x","article-title":"Treatment of refractory status epilepticus with pentobarbital, propofol, or midazolam: a systematic review","volume":"43","author":"Claassen","year":"2002","journal-title":"Epilepsia"},{"issue":"11","key":"10.1002\/14651858.CD009202.pub2-BIB3|cit3","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"key":"10.1002\/14651858.CD009202.pub2-BIB4|cit4","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD009202.pub2-BIB5|cit5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/WCO.0b013e328042bacb","article-title":"The anaesthetic and intensive care of status epilepticus","volume":"20","author":"Holtkamp","year":"2007","journal-title":"Current Opinion in Neurology"},{"key":"10.1002\/14651858.CD009202.pub2-BIB6|cit6","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"29","key":"10.1002\/14651858.CD009202.pub2-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.2174\/1381612043382846","article-title":"Propofol: therapeutic indications and side effects","volume":"10","author":"Marik","year":"2004","journal-title":"Current Pharmaceutical Design"},{"issue":"2","key":"10.1002\/14651858.CD009202.pub2-BIB8|cit8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Archives of Neurology"},{"issue":"8","key":"10.1002\/14651858.CD009202.pub2-BIB9|cit9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1212\/01.WNL.0000032253.88378.D7","article-title":"High-dose thiopental in the treatment of refractory status epilepticus in intensive care unit","volume":"59","author":"Parviainen","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"10.1002\/14651858.CD009202.pub2-BIB10|cit10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003723.pub2","article-title":"Anticonvulsant therapy for status epilepticus","author":"Prasad","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009202.pub2-BIB11|cit11","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"7","key":"10.1002\/14651858.CD009202.pub2-BIB12|cit12","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrn1430","article-title":"The neurobiology of antiepileptic drugs","volume":"5","author":"Rogowski","year":"2004","journal-title":"Nature Reviews Neuroscience"},{"issue":"11","key":"10.1002\/14651858.CD009202.pub2-BIB13|cit13","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1001\/archneur.62.11.1698","article-title":"Refractory status epilepticus. Effects of treatment aggressiveness on prognosis","volume":"62","author":"Rossetti","year":"2005","journal-title":"Archives of Neurology"},{"issue":"12","key":"10.1002\/14651858.CD009202.pub2-BIB14|cit14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus:\u00a0Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD009202.pub2-BIB15|cit15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.wnl.0000173066.89001.f9","article-title":"Propofol and thiopental for refractory status epilepticus in children","volume":"65","author":"Gestel","year":"2005","journal-title":"Neurology"},{"issue":"7","key":"10.1002\/14651858.CD009202.pub2-BIB16|cit16","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jama.1993.03510070076040","article-title":"Treatment of convulsive status epilepticus. Recommendations of the Epilepsy Foundation of America's Working Group on Status Epilepticus","volume":"270","year":"1993","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD009202.pub2-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1528-1167.2007.01042.x","article-title":"Propofol-associated fatal myocardial failure and rhabdomyolysis in an adult with status epilepticus","volume":"48","author":"Zarovnaya","year":"2007","journal-title":"Epilepsia"},{"issue":"4","key":"10.1002\/14651858.CD009202.pub2-BIB18|cit18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00003246-200104000-00026","article-title":"Intravenous anaesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-D-aspartate receptor inhibition","volume":"29","author":"Zhan","year":"2001","journal-title":"Critical Care Medicine"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD009202.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:29:18Z","timestamp":1628533758000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD009202.pub2"}},"subtitle":[],"editor":[{"given":"Hemanshu","family":"Prabhakar","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":18,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009202.pub2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717954899.793463891","asserted-by":"object"}]},"subject":[],"published":{"date-parts":[[2012,8,15]]}}}